Chief Operating Officer and Head of R&D Operations
Education: MSc, PhD
Background: Maj Hedtjärn brings more than 15 years of experience in drug discovery & development, program management and pharma alliance management from the biotech and pharmaceutical industry (Roche, Santaris Pharma and Lundbeck), where she has held numerous leadership positions within R&D. Prior to joining Scandion Oncology, she most recently served as VP & Head of Drug Discovery, RNA Therapeutics Research at Roche Innovation Center Copenhagen.
Other ongoing assignments: Scientific Advisor to Lipigon Pharmaceuticals AB
Scandion Oncology shares and warrants
24,000 shares (owned via Venilia Holding ApS)